{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:04:42Z","timestamp":1784639082781,"version":"3.55.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["U01 EB034694"],"award-info":[{"award-number":["U01 EB034694"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["U01 EB034694"],"award-info":[{"award-number":["U01 EB034694"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R44 EB035078"],"award-info":[{"award-number":["R44 EB035078"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute","award":["R44 CA285064"],"award-info":[{"award-number":["R44 CA285064"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["R44 DA041814"],"award-info":[{"award-number":["R44 DA041814"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ImPAKT Facility"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sentinel lymph node (SLN) mapping is essential for cancer staging and treatment planning. Superparamagnetic iron oxides (SPIOs) are used for magnetic SLN localization in breast cancer and are being explored in cancers with complex lymphatic drainage pathways. Magnetic particle imaging (MPI) directly detects SPIOs and has demonstrated feasibility for quantitative lymphography in mouse models. However, most MPI studies have relied on preclinical SPIO formulations not intended for human use. Here, we evaluated three clinically available or investigational SPIOs for MPI, including Magtrace, Resotran, and FerroTrace. SPIOs were characterized in vitro using 2D MPI and relaxometry, benchmarked against the preclinical standard VivoTrax. Magtrace and Resotran demonstrated in vitro performance comparable to VivoTrax, whereas FerroTrace exhibited lower peak signal and resolution by relaxometry. In vivo longitudinal MPI lymphography was performed in healthy C57BL\/6 mice following intradermal injection of SPIOs. Magtrace and FerroTrace produced robust lymph node labeling, with MPI signal persisting for at least four weeks across all SPIOs. Feasibility of clinical-scale MPI for complex lymphatic mapping was demonstrated using a human-sized head-and-neck phantom modeling bilateral lymphatic drainage. Together, these results establish Magtrace, Resotran, and FerroTrace as suitable magnetic tracers for MPI lymphography and support their use in future human MPI applications.<\/jats:p>","DOI":"10.1038\/s44303-026-00182-7","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:15:09Z","timestamp":1784603709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Magnetic particle imaging tracers for human applications: preclinical in vivo evaluation of Magtrace, Resotran, and FerroTrace"],"prefix":"10.1038","volume":"4","author":[{"given":"Olivia C.","family":"Sehl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitara","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rahman","family":"Mohtasebzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Fellows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thierry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Weyhmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Greve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Goodwill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"182_CR1","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1586\/14737140.6.10.1503","volume":"6","author":"A Ferrari","year":"2006","unstructured":"Ferrari, A. et al. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer. Expert Rev. Anticancer Ther. 6, 1503\u20131515 (2006).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"182_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clindermatol.2012.08.004","volume":"31","author":"MI Ross","year":"2013","unstructured":"Ross, M. I. & Gershenwald, J. E. Sentinel lymph node biopsy for melanoma: A critical update for dermatologists after two decades of experience. Clin. Dermatol. 31, 298\u2013310 (2013).","journal-title":"Clin. Dermatol."},{"key":"182_CR3","doi-asserted-by":"crossref","unstructured":"Monroe, M. M. & Lai, S. Y. Sentinel lymph node biopsy for oral cancer: supporting evidence and recent novel developments. Curr. Oncol. Rep. 16, 385 (2014).","DOI":"10.1007\/s11912-014-0385-1"},{"key":"182_CR4","doi-asserted-by":"crossref","unstructured":"Leong, S. P. et al. Preoperative and Intraoperative Identification of Sentinel Lymph Nodes in Melanoma Surgery. Cancers 16, 2767 (2024).","DOI":"10.3390\/cancers16152767"},{"key":"182_CR5","doi-asserted-by":"crossref","unstructured":"Chan, K., Saltagi, M. & Choi, K. Y. The emerging role of sentinel lymph node biopsy in oral cavity and oropharyngeal carcinomas. Plastic and Aesthetic Research, 11 (2024).","DOI":"10.20517\/2347-9264.2023.79"},{"key":"182_CR6","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.3390\/cancers15102736","volume":"15","author":"L Ah-Thiane","year":"2023","unstructured":"Ah-Thiane, L. et al. The sentinel lymph node in treatment planning: a narrative review of lymph-flow-guided radiotherapy. Cancers 15, 2736 (2023).","journal-title":"Cancers"},{"key":"182_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1748-717X-9-121","volume":"9","author":"JF Daisne","year":"2014","unstructured":"Daisne, J. F. et al. SPECT\/CT lymphoscintigraphy of sentinel node(s) for superselective prophylactic irradiation of the neck in cN0 head and neck cancer patients: a prospective phase I feasibility study. Radiat. Oncol. 9, 121 (2014).","journal-title":"Radiat. Oncol."},{"key":"182_CR8","doi-asserted-by":"crossref","unstructured":"De Veij Mestdagh, P. D. et al. Mapping of sentinel lymph node drainage using SPECT\/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial. BMC Cancer 19, 1110 (2019).","DOI":"10.1186\/s12885-019-6331-8"},{"key":"182_CR9","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/cancers12103055","volume":"12","author":"R Mahieu","year":"2020","unstructured":"Mahieu, R. et al. New developments in imaging for sentinel lymph node biopsy in early-stage oral cavity squamous cell carcinoma. Cancers 12, 3055 (2020).","journal-title":"Cancers"},{"key":"182_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00259-020-04984-8","volume":"48","author":"IJ den Toom","year":"2021","unstructured":"den Toom, I. J. et al. Sentinel lymph node detection in oral cancer: a within-patient comparison between [99mTc]Tc-tilmanocept and [99mTc]Tc-nanocolloid. Eur. J. Nucl. Med. Mol. Imaging 48, 851\u2013858 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"182_CR11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/jso.25747","volume":"120","author":"K Taruno","year":"2019","unstructured":"Taruno, K. et al. Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe. J. Surg. Oncol. 120, 1391\u20131396 (2019).","journal-title":"J. Surg. Oncol."},{"key":"182_CR12","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1245\/s10434-019-07577-4","volume":"26","author":"MD Alvarado","year":"2019","unstructured":"Alvarado, M. D. et al. SentimagIC: a non-inferiority trial comparing superparamagnetic iron oxide versus technetium-99m and blue dye in the detection of axillary sentinel nodes in patients with early-stage breast cancer. Ann. Surg. Oncol. 26, 3510\u20133516 (2019).","journal-title":"Ann. Surg. Oncol."},{"key":"182_CR13","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1245\/s10434-013-3379-6","volume":"21","author":"M Douek","year":"2014","unstructured":"Douek, M. et al. Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG multicentre trial. Ann. Surg. Oncol. 21, 1237\u20131245 (2014).","journal-title":"Ann. Surg. Oncol."},{"key":"182_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.breast.2014.01.004","volume":"23","author":"M Thill","year":"2014","unstructured":"Thill, M. et al. The Central-European SentiMag study: Sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. The Breast 23, 175\u2013179 (2014).","journal-title":"The Breast"},{"key":"182_CR15","unstructured":"Endomagnetics Ltd. Summary of Safety and Effectiveness Data: Magtrace\u00ae and Sentimag\u00ae Magnetic Localization System (2022)."},{"key":"182_CR16","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1245\/s10434-024-16626-6","volume":"32","author":"A Christenhusz","year":"2025","unstructured":"Christenhusz, A. et al. Magnetic sentinel lymph node biopsy in early breast cancer patients: an individual patient data meta-analysis of tracer uptake. Ann. Surg. Oncol. 32, 2079\u20132091 (2025).","journal-title":"Ann. Surg. Oncol."},{"key":"182_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ejso.2021.12.467","volume":"48","author":"N Mirzaei","year":"2022","unstructured":"Mirzaei, N. et al. Sentinel lymph node localization and staging with a low-dose of superparamagnetic iron oxide (SPIO) enhanced MRI and magnetometer in patients with cutaneous melanoma of the extremity - The MAGMEN feasibility study. Eur. J. Surg. Oncol. 48, 326\u2013332 (2022).","journal-title":"Eur. J. Surg. Oncol."},{"key":"182_CR18","doi-asserted-by":"publisher","first-page":"107320","DOI":"10.1016\/j.ejso.2023.107804","volume":"50","author":"L Aldenhoven","year":"2024","unstructured":"Aldenhoven, L. et al. Exploring an alternative pre-operative sentinel lymph node mapping method using a magnetic tracer and MRI for melanoma patients - SCARLETT study. Eur. J. Surg. Oncol. 50, 107320 (2024).","journal-title":"Eur. J. Surg. Oncol."},{"key":"182_CR19","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/j.ejso.2014.08.101","volume":"40","author":"M Douek","year":"2014","unstructured":"Douek, M. et al. Sentinel lymph node biopsy for melanoma using a magnetic technique: Primary outcome of the MELAMAG Multicentre Trial. Eur. J. Surg. Oncol. (EJSO) 40, S50 (2014).","journal-title":"Eur. J. Surg. Oncol. (EJSO)"},{"key":"182_CR20","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1245\/s10434-016-5113-7","volume":"23","author":"B Anninga","year":"2016","unstructured":"Anninga, B. et al. Magnetic technique for sentinel lymph node biopsy in melanoma: the MELAMAG trial. Ann. Surg. Oncol. 23, 2070\u20132078 (2016).","journal-title":"Ann. Surg. Oncol."},{"key":"182_CR21","doi-asserted-by":"crossref","unstructured":"Nieuwenhuis, E. R. et al. A complete magnetic sentinel lymph node biopsy procedure in oral cancer patients: A pilot study. Oral Oncol. 121, 105464 (2021).","DOI":"10.1016\/j.oraloncology.2021.105464"},{"key":"182_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jso.25810","volume":"121","author":"J Hernando","year":"2020","unstructured":"Hernando, J. et al. Magnetic detection of sentinel nodes in oral squamous cell carcinoma by means of superparamagnetic iron oxide contrast. J. Surg. Oncol. 121, 244\u2013248 (2020).","journal-title":"J. Surg. Oncol."},{"key":"182_CR23","doi-asserted-by":"crossref","unstructured":"Donders, D. N. V. et al. Magnetic sentinel lymph node detection using superparamagnetic iron oxide in early-stage oral squamous cell carcinoma: design and rationale of the multicenter magnetics trial \u2013 study protocol. BMC Cancer 25, 1539 (2025).","DOI":"10.1186\/s12885-025-14866-7"},{"key":"182_CR24","doi-asserted-by":"crossref","unstructured":"Krishnan, G. et al. Preclinical evaluation of a mannose-labeled magnetic tracer for enhanced sentinel lymph node retention in the head and neck. Nanomedicine 42, 102546 (2022).","DOI":"10.1016\/j.nano.2022.102546"},{"key":"182_CR25","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1002\/hed.27177","volume":"44","author":"G Krishnan","year":"2022","unstructured":"Krishnan, G. et al. Preclinical feasibility of robot-assisted sentinel lymph node biopsy using multi-modality magnetic and fluorescence guidance in the head and neck. Head. Neck 44, 2696\u20132707 (2022).","journal-title":"Head. Neck"},{"key":"182_CR26","doi-asserted-by":"publisher","first-page":"6185","DOI":"10.1007\/s00464-023-10099-6","volume":"37","author":"A Cousins","year":"2023","unstructured":"Cousins, A. et al. Preclinical evaluation of sentinel node localization in the stomach via mannose-labelled magnetic nanoparticles and indocyanine green. Surg. Endosc. 37, 6185\u20136196 (2023).","journal-title":"Surg. Endosc."},{"key":"182_CR27","doi-asserted-by":"crossref","unstructured":"Krishnan, G. et al. Mannose-labelled magnetic nanoparticles for sentinel lymph node biopsy in oral squamous cell carcinoma: Initial results from a phase 1 clinical trial. Eur. J. Surg. Oncol. 51, 110221 (2025).","DOI":"10.1016\/j.ejso.2025.110221"},{"key":"182_CR28","doi-asserted-by":"crossref","unstructured":"Bukhari, S. M. A. et al. Lymphoscintigraphy in cutaneous melanoma: usual and unexpected pathways of lymphatic drainage. Clin. Radiol. 96, 107221 (2025).","DOI":"10.1016\/j.crad.2025.107221"},{"key":"182_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jmr.2012.11.029","volume":"229","author":"EU Saritas","year":"2013","unstructured":"Saritas, E. U. et al. Magnetic particle imaging (MPI) for NMR and MRI researchers. J. Magn. Reson. 229, 116\u2013126 (2013).","journal-title":"J. Magn. Reson."},{"key":"182_CR30","doi-asserted-by":"publisher","first-page":"umae024","DOI":"10.1093\/radadv\/umae024","volume":"1","author":"OC Sehl","year":"2024","unstructured":"Sehl, O. C. et al. Magnetic particle imaging enables nonradioactive quantitative sentinel lymph node identification: feasibility proof in murine models. Radiol. Adv. 1, umae024 (2024).","journal-title":"Radiol. Adv."},{"key":"182_CR31","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1039\/D5NR03104D","volume":"18","author":"N Fernando","year":"2026","unstructured":"Fernando, N., Sehl, O. C., Fellows, B., Saayujya, C. & Foster, P. J. Magnetic particle imaging lymphography (MPIL): a technique for lymph node mapping. Nanoscale 18, 3018\u20133031 (2026).","journal-title":"Nanoscale"},{"key":"182_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.addr.2018.12.007","volume":"138","author":"JWM Bulte","year":"2019","unstructured":"Bulte, J. W. M. Superparamagnetic iron oxides as MPI tracers: a primer and review of early applications. Adv. Drug Deliv. Rev. 138, 293\u2013301 (2019).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"182_CR33","doi-asserted-by":"crossref","unstructured":"Guo, Z. et al. Superparamagnetic iron oxide nanoparticles in clinical applications: current status and future perspectives. EBioMedicine 122, (2025).","DOI":"10.1016\/j.ebiom.2025.106054"},{"key":"182_CR34","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00330-002-1721-7","volume":"13","author":"P Reimer","year":"2003","unstructured":"Reimer, P. & Balzer, T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur. Radiol. 13, 1266\u20131276 (2003).","journal-title":"Eur. Radiol."},{"key":"182_CR35","unstructured":"PDR Pharma Co. Ltd. Resovist (ferucarbotran injection) Prescribing Information. JAPIC. https:\/\/pins.japic.or.jp\/pdf\/newPINS\/00049238.pdf (2022)."},{"key":"182_CR36","unstructured":"b.e.Imaging GmbH. Resotran (ferucarbotran injection) product information. https:\/\/www.fachinfo.de\/pdf\/023940 (2024)."},{"key":"182_CR37","doi-asserted-by":"crossref","unstructured":"Mohn, F. et al. Characterization of the clinically approved MRI tracer resotran for magnetic particle imaging in a comparison study. Phys. Med. Biol. 69, 135014 (2024).","DOI":"10.1088\/1361-6560\/ad5828"},{"key":"182_CR38","unstructured":"Hartung, V. et al. Resotran\u00ae meets MPI \u2013 clinically approved Ferucarbotran reintroduced: a major leap towards MPI in humans. Int. J. Magn. Part. Imaging 9, 635 (2023)."},{"key":"182_CR39","unstructured":"AMAG Pharmaceuticals. Prescribing Information Feraheme (Ferumoxytol) Revised: 06\/2022 (AMAG Pharmaceuticals, Inc., 2022)."},{"key":"182_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.kint.2016.12.037","volume":"92","author":"GB Toth","year":"2017","unstructured":"Toth, G. B. et al. Current and potential imaging applications of ferumoxytol for magnetic resonance imaging. Kidney Int 92, 47\u201366 (2017).","journal-title":"Kidney Int"},{"key":"182_CR41","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00247-021-05098-5","volume":"52","author":"HE Daldrup-Link","year":"2022","unstructured":"Daldrup-Link, H. E. et al. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol. Pediatric radiology 52, 354\u2013366 (2022).","journal-title":"Pediatric radiology"},{"key":"182_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1148\/radiol.2018181204","volume":"290","author":"M Iv","year":"2019","unstructured":"Iv, M. et al. Quantification of macrophages in high-grade gliomas by using ferumoxytol-enhanced MRI: a pilot study. Radiology 290, 198\u2013206 (2019).","journal-title":"Radiology"},{"key":"182_CR43","unstructured":"Azurity Pharmaceuticals. Ferabright (ferumoxytol injection) Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/219868s000lbl.pdf (U.S. Food and Drug Administration, 2025)."},{"key":"182_CR44","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1148\/radiol.2283020872","volume":"228","author":"CW Piccoli","year":"2003","unstructured":"Piccoli, C. W. et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study 1. Radiology 228, 777\u2013788 (2003).","journal-title":"Radiology"},{"key":"182_CR45","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.1007\/s00330-024-10838-w","volume":"34","author":"G Litjens","year":"2024","unstructured":"Litjens, G. et al. Ferumoxtran-10-enhanced MRI for pre-operative metastatic lymph node detection in pancreatic, duodenal, or periampullary adenocarcinoma. Eur. Radiol. 34, 7973\u20137984 (2024).","journal-title":"Eur. Radiol."},{"key":"182_CR46","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11307-018-1276-x","volume":"21","author":"H Nejadnik","year":"2019","unstructured":"Nejadnik, H. et al. Ferumoxytol can be used for quantitative magnetic particle imaging of transplanted stem cells. Mol. Imaging Biol. 21, 465\u2013472 (2019).","journal-title":"Mol. Imaging Biol."},{"key":"182_CR47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s11307-020-01473-0","volume":"22","author":"AV Makela","year":"2020","unstructured":"Makela, A. V. et al. Magnetic particle imaging of macrophages associated with cancer: filling the voids left by iron-based magnetic resonance imaging. Mol. Imaging Biol. 22, 958\u2013968 (2020).","journal-title":"Mol. Imaging Biol."},{"key":"182_CR48","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s41467-019-09704-x","volume":"10","author":"M Graeser","year":"2019","unstructured":"Graeser, M. et al. Human-sized magnetic particle imaging for brain applications. Nat. Commun. 10, 1936 (2019).","journal-title":"Nat. Commun."},{"key":"182_CR49","doi-asserted-by":"publisher","first-page":"e0193546","DOI":"10.1371\/journal.pone.0193546","volume":"13","author":"J Rahmer","year":"2018","unstructured":"Rahmer, J., Stehning, C. & Gleich, B. Remote magnetic actuation using a clinical scale system. PLoS ONE 13, e0193546 (2018).","journal-title":"PLoS ONE"},{"key":"182_CR50","doi-asserted-by":"publisher","first-page":"015019","DOI":"10.1088\/1361-6560\/ad9db0","volume":"70","author":"E Mattingly","year":"2025","unstructured":"Mattingly, E. et al. Design, construction and validation of a magnetic particle imaging (MPI) system for human brain imaging. Phys. Med. Biol. 70, 015019 (2025).","journal-title":"Phys. Med. Biol."},{"key":"182_CR51","unstructured":"Ferronova Pty Ltd. DOC-133 FerroTrace Product Description, 2 (2023)."},{"key":"182_CR52","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s11307-023-01829-2","volume":"25","author":"HJ Good","year":"2023","unstructured":"Good, H. J. et al. Inter-user comparison for quantification of superparamagnetic iron oxides with magnetic particle imaging across two institutions highlights a need for standardized approaches. Mol. Imaging Biol. 25, 954\u2013967 (2023).","journal-title":"Mol. Imaging Biol."},{"key":"182_CR53","doi-asserted-by":"crossref","unstructured":"Pedro, L., Harmer, Q., Mayes, E. & Shields, J. D. Impact of locally administered carboxydextran-coated super-paramagnetic iron nanoparticles on cellular immune function. Small 15, 1900224 (2019).","DOI":"10.1002\/smll.201900224"},{"key":"182_CR54","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.nano.2015.01.010","volume":"11","author":"M Ahmed","year":"2015","unstructured":"Ahmed, M. et al. Optimising magnetic sentinel lymph node biopsy in an in vivo porcine model. Nanomedicine 11, 993\u20131002 (2015).","journal-title":"Nanomedicine"},{"key":"182_CR55","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.3390\/cancers13195031","volume":"13","author":"MCL Peek","year":"2021","unstructured":"Peek, M. C. L. et al. Optimization of SPIO injection for sentinel lymph node dissection in a rat model. Cancers 13, 5031 (2021).","journal-title":"Cancers"},{"key":"182_CR56","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.ejso.2020.06.018","volume":"46","author":"IT Rubio","year":"2020","unstructured":"Rubio, I. T. et al. A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: the SUNRISE study. Eur. J. Surg. Oncol. 46, 2195\u20132201 (2020).","journal-title":"Eur. J. Surg. Oncol."},{"key":"182_CR57","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1245\/s10434-022-13064-0","volume":"30","author":"A Karakatsanis","year":"2023","unstructured":"Karakatsanis, A. et al. Delayed sentinel lymph node dissection in patients with a preoperative diagnosis of ductal cancer in situ by preoperative injection with superparamagnetic iron oxide (SPIO) nanoparticles: the sentinot study. Ann. Surg. Oncol. 30, 4064\u20134072 (2023).","journal-title":"Ann. Surg. Oncol."},{"key":"182_CR58","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1177\/00031348241244634","volume":"90","author":"G Muanamputu","year":"2024","unstructured":"Muanamputu, G., Sparkman, B. K., Louie, R. J. & McGuire, K. P. Clinical longevity of preoperative injection of superparamagnetic iron oxide nanoparticles for delayed sentinel lymph node biopsy. Am. Surg. 90, 2110\u20132113 (2024).","journal-title":"Am. Surg."},{"key":"182_CR59","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10549-024-07482-9","volume":"209","author":"M Samaha","year":"2025","unstructured":"Samaha, M., Fellner, A., Raque, K., Kuritzky, A. & Wexelman, B. Magnetic lymphatic tracing for omission of sentinel lymph node biopsies in mastectomy patients: a community cancer center experience. Breast Cancer Res. Treat. 209, 161\u2013166 (2025).","journal-title":"Breast Cancer Res. Treat."},{"key":"182_CR60","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/ans.18936","volume":"94","author":"RBJ Cui","year":"2024","unstructured":"Cui, R. B. J. et al. Avoiding unnecessary sentinel lymph node biopsy with the use of superparamagnetic iron oxide mapping agents (Magtrace\u00ae) in breast surgery. ANZ J. Surg. 94, 1090\u20131095 (2024).","journal-title":"ANZ J. Surg."},{"key":"182_CR61","doi-asserted-by":"publisher","first-page":"E5466","DOI":"10.1097\/GOX.0000000000005466","volume":"11","author":"JL Bryan","year":"2023","unstructured":"Bryan, J. L. et al. The novel use of magtrace in chest masculinizing transgender top surgery. Plast. Reconstr. Surg. Glob. Open 11, E5466 (2023).","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"182_CR62","doi-asserted-by":"publisher","first-page":"e00081","DOI":"10.1097\/JU9.0000000000000183","volume":"2","author":"L Molenaar","year":"2024","unstructured":"Molenaar, L. et al. Sentinel lymph node mapping in prostate cancer: magnetic route. JU Open Plus 2, e00081 (2024).","journal-title":"JU Open Plus"},{"key":"182_CR63","doi-asserted-by":"crossref","unstructured":"Reinhardt, M. J., Ohmstede, B., Torres-de la Roche, L. A. & De Wilde, R. L. Is preoperative imaging of sentinel lymph node in breast cancer necessary? A retrospective case control study. Breast 79, 103856 (2025).","DOI":"10.1016\/j.breast.2024.103856"},{"key":"182_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000549828","volume":"67","author":"L Aldenhoven","year":"2026","unstructured":"Aldenhoven, L. et al. Exploring an alternative preoperative sentinel lymph node mapping method using a magnetic tracer and magnetic resonance imaging for melanoma patients: Scarlett study protocol. Eur. Surg. Res. 67, 30\u201337 (2026).","journal-title":"Eur. Surg. Res."},{"key":"182_CR65","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jamcollsurg.2008.08.008","volume":"207","author":"LC Liu","year":"2008","unstructured":"Liu, L. C. et al. Is It Necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer?. J. Am. Coll. Surg. 207, 853\u2013858 (2008).","journal-title":"J. Am. Coll. Surg."},{"key":"182_CR66","doi-asserted-by":"crossref","unstructured":"Gau, M. et al. Unilateral vs bilateral neck irradiation: the importance of careful patient selection in tailoring radiation therapy for lateralized palatine-tonsil and non-palatine-tonsil oropharyngeal carcinoma. Radiother. Oncol. 210, 111049 (2025).","DOI":"10.1016\/j.radonc.2025.111049"},{"key":"182_CR67","doi-asserted-by":"crossref","unstructured":"De Almeida, J. R. et al. SPECT-CT guided elective contralateral neck treatment (SELECT) for patients with lateralized oropharyngeal cancer-a phase III randomized controlled trial. J. Clin. Oncol. 41, TPS6114\u2013TPS6114 (2023).","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS6114"},{"key":"182_CR68","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00405-025-09840-9","volume":"283","author":"A Al-Mamgani","year":"2025","unstructured":"Al-Mamgani, A. et al. SPECT\/CT-based sentinel node procedure to guide unilateral elective nodal irradiation in patients with head and neck cancer: technical feasibility and sentinel node mapping outcomes. Eur. Arch. Oto-Rhino-Laryngol 283, 1017\u20131026 (2025).","journal-title":"Eur. Arch. Oto-Rhino-Laryngol"},{"key":"182_CR69","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1002\/cncr.30204","volume":"122","author":"V Divi","year":"2016","unstructured":"Divi, V. et al. Establishing quality indicators for neck dissection: correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234). Cancer 122, 3464\u20133471 (2016).","journal-title":"Cancer"},{"key":"182_CR70","doi-asserted-by":"crossref","unstructured":"Nieuwenhuis, E. R. et al. A comprehensive grading system for a magnetic sentinel lymph node biopsy procedure in head and neck cancer patients. Cancers 14, 678 (2022).","DOI":"10.3390\/cancers14030678"},{"key":"182_CR71","doi-asserted-by":"crossref","unstructured":"Sekino, M. et al. Handheld magnetic probe with permanent magnet and Hall sensor for identifying sentinel lymph nodes in breast cancer patients. Sci. Rep. 8, 1195 (2018).","DOI":"10.1038\/s41598-018-19480-1"},{"key":"182_CR72","doi-asserted-by":"crossref","unstructured":"Taruno, K. et al. Exploratory study of superparamagnetic iron oxide dose optimization in breast cancer sentinel lymph node identification using a handheld magnetic probe and iron quantitation. Cancers 14, 1409 (2022).","DOI":"10.3390\/cancers14061409"},{"key":"182_CR73","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1148\/radiol.2018180449","volume":"289","author":"JWM Bulte","year":"2018","unstructured":"Bulte, J. W. M. & Daldrup-Link, H. E. Clinical tracking of cell transfer and cell transplantation: trials and tribulations. Radiology 289, 604\u2013615 (2018).","journal-title":"Radiology"},{"key":"182_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s43856-025-00794-x","volume":"5","author":"V Hartung","year":"2025","unstructured":"Hartung, V. et al. Magnetic particle imaging angiography of the femoral artery in a human cadaveric perfusion model. Commun. Med. 5, 75 (2025).","journal-title":"Commun. Med."},{"key":"182_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijcard.2011.06.004","volume":"163","author":"A Yilmaz","year":"2013","unstructured":"Yilmaz, A. et al. Magnetic resonance imaging (MRI) of inflamed myocardium using iron oxide nanoparticles in patients with acute myocardial infarction - preliminary results. Int. J. Cardiol. 163, 175\u2013182 (2013).","journal-title":"Int. J. Cardiol."},{"key":"182_CR76","doi-asserted-by":"crossref","unstructured":"Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).","DOI":"10.1038\/natrevmats.2016.14"},{"key":"182_CR77","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.7150\/thno.122259","volume":"16","author":"P Korangath","year":"2026","unstructured":"Korangath, P. et al. Nanoparticle retention enables non-invasive detection of metastases by magnetic particle imaging in murine breast cancer models. Nanotheranostics 16, 2136 (2026).","journal-title":"Nanotheranostics"},{"key":"182_CR78","unstructured":"Fernando, N., Gevaert, J. J., Konkle, J., Goodwill, P. & Foster, P. J. Focused small field of view magnetic particle imaging for the isolation and quantification of MPI signal in tumours. Int. J. Magn. Part. Imaging 10, 790 (2024)."},{"key":"182_CR79","doi-asserted-by":"publisher","first-page":"2100796","DOI":"10.1002\/smtd.202100796","volume":"5","author":"ZW Tay","year":"2021","unstructured":"Tay, Z. W. et al. Superferromagnetic nanoparticles enable order-of-magnitude resolution & sensitivity gain in magnetic particle imaging. Small Methods 5, 2100796 (2021).","journal-title":"Small Methods"},{"key":"182_CR80","doi-asserted-by":"publisher","first-page":"7356","DOI":"10.1126\/sciadv.ado7356","volume":"11","author":"AC Velazquez-Albino","year":"2025","unstructured":"Velazquez-Albino, A. C., Daniel Imhoff, E. & Rinaldi-Ramos, C. M. Advances in engineering nanoparticles for magnetic particle imaging (MPI). Sci. Adv. 11, 7356 (2025).","journal-title":"Sci. Adv."},{"key":"182_CR81","unstructured":"Lu, K. Linearity, Shift-Invariance and Resolution Improvement for Quantitative Magnetic Particle Imaging, 10186579 (University of California, ProQuest Dissertations Publishing, 2015)."},{"key":"182_CR82","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1109\/TMI.2025.3530316","volume":"44","author":"T Sanders","year":"2025","unstructured":"Sanders, T. et al. A physics-based computational forward model for efficient image reconstruction in magnetic particle imaging. IEEE Trans. Med. Imaging 44, 2319\u20132329 (2025).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"182_CR83","unstructured":"Sanders, T. et al. A field free line 3D reconstruction model for magnetic particle imaging for improved sensitivity, resolution, and high dynamic range imaging. http:\/\/arxiv.org\/abs\/2511.06627 (2025)."},{"key":"182_CR84","doi-asserted-by":"crossref","unstructured":"Sehl, O. C. et al. MPI region of interest (ROI) analysis and quantification of iron in different volumes. Int. J. Magn. Part. Imaging 8, 478 (2022).","DOI":"10.1101\/2022.04.10.487778"},{"key":"182_CR85","doi-asserted-by":"crossref","unstructured":"Sanders, T., Konkle, J. J., Mason, E. E. & Goodwill, P. W. Multi-harmonic gridded 3D deconvolution (MH3D) for robust and accurate image reconstruction in MPI for single axis drive field scanners. Phys. Med. Biol. 70, 235001 (2025).","DOI":"10.1088\/1361-6560\/ae1c8f"},{"key":"182_CR86","unstructured":"VivoTrax [Datasheet]. Magnetic Insight Inc., Alameda, CA USA."},{"key":"182_CR87","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3109\/00016489.2012.744143","volume":"133","author":"D Mizokami","year":"2013","unstructured":"Mizokami, D. et al. Superparamagnetic iron oxide-enhanced interstitial magnetic resonance lymphography to detect a sentinel lymph node in tongue cancer patients. Acta Otolaryngol. 133, 418\u2013423 (2013).","journal-title":"Acta Otolaryngol."},{"key":"182_CR88","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jormas.2022.01.003","volume":"123","author":"S Sugiyama","year":"2022","unstructured":"Sugiyama, S. et al. Sentinel lymph node biopsy with a handheld cordless magnetic probe following preoperative MR lymphography using superparamagnetic iron oxide for clinically N0 early oral cancer: A feasibility study. J. Stomatol. Oral. Maxillofac. Surg. 123, 521\u2013526 (2022).","journal-title":"J. Stomatol. Oral. Maxillofac. Surg."}],"container-title":["npj Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44303-026-00182-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44303-026-00182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44303-026-00182-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:43:32Z","timestamp":1784637812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44303-026-00182-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1038\/s44303-026-00182-7","relation":{},"ISSN":["2948-197X"],"issn-type":[{"value":"2948-197X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"At the time of the study, all authors employed by Magnetic Insight, Inc. were stockholders in the company. Magnetic Insight, Inc. is no longer in business at the time of manuscript submission. The authors declare no competing non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"48"}}